News Image

Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers

Provided By GlobeNewswire

Last update: Jun 25, 2024

The pooled analysis included data from 4 international clinical trials spanning an array of hard-to-treat indications including skin, head & neck, and oral cavity.

Read more at globenewswire.com

ALPHA TAU MEDICAL LTD

NASDAQ:DRTS (6/26/2025, 1:57:11 PM)

3.02

+0.02 (+0.67%)


ALPHA TAU MEDICAL LTD -27

NASDAQ:DRTSW (6/26/2025, 1:48:19 PM)

0.2498

0 (-0.04%)



Find more stocks in the Stock Screener

Follow ChartMill for more